Apotex Enjoined From Launching Generic Pulmicort
AstraZeneca Pharmaceuticals LP has been granted a preliminary injunction in its suit to prevent Apotex Inc. from launching a generic version of children's asthma treatment Pulmicort Respules, a month after a...To view the full article, register now.
Already a subscriber? Click here to view full article